Antengene - Insights on Pipeline and Valuation
This article analyzed the value and potential of Antengene's current pipeline, its competitors' products and also include some thoughts on valuation.
276 Views
A Different Angle - RemeGen Vs Akeso (Insights on Valuation)
In this article, by comparing RemeGen and Akeso's pipelines from different aspects to provide referable and helpful insights about the valuation...
341 Views
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
327 Views
ECM Weekly (11 October 2020) - Excellence Comm, MR DIY, Converge ICT, Simcere, SciClone, JW Thera
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
351 Views
A Different Angle - Simcere Pharmaceutical VS Everest Medicines (01952.HK)
Everest Medicines was listed in Hong Kong stock market on October 9, 2020 and closed at HK$72.75 (up 32.27% on the first day) . From the...
350 Views